The purpose of this study is to determine is Denileukin diftitox will be safe, well tolerated
and induce a significant overall response alone and in combination with chemotherapy:
ifosfamide, carboplatin and etoposide (ICE) and will be safe and well tolerated in a
population of children, adolescents and young adults with relapsed or refractory anaplastic
large cell lymphoma (ALCL).